AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Merck Q2 Earnings Preview: Analysts Expect 11% Decline in EPS and 1.4% Revenue Decrease
ByAinvest
Monday, Jul 28, 2025 7:57 pm ET1min read
Merck is set to report Q2 earnings on July 29th, with analysts expecting an 11% decline in EPS to $2.03 and a 1.4% decrease in revenue to $15.87B.
Merck & Co., Inc. (NYSE:MRK) is set to report its second-quarter earnings on Tuesday, July 29th, before the opening bell. Analysts expect an 11% decline in earnings per share (EPS) to $2.03, with a 1.4% decrease in revenue to $15.87 billion [3]. This comes as Merck navigates several challenges, including the failure of its Reblozyl anemia therapy in a Phase 3 trial for myelofibrosis and the start of late-stage clinical trials for its oral drug, MK-8527, aimed at preventing HIV [3].Despite these setbacks, Merck has a history of beating expectations. Over the last eight quarters, the company has consistently surpassed EPS and revenue estimates, with a 88% success rate for EPS and 100% for revenue [3]. However, recent market trends suggest a 4.9% swing for Merck shares, with an average daily move of 4.2% on earnings days [2].
Investors are also watching Merck's dividend yield, currently at 3.82% annually, or 81 cents per share per quarter. To generate $500 monthly, an investor would need to own approximately 1,852 shares, valued at around $156,883 [1]. For a more conservative goal of $100 monthly, 370 shares, valued at $31,343, would be sufficient [1].
Merck's stock has seen a 15.3% year-to-date decline, compared to a 1.9% decline for the S&P 500 healthcare index and a 5.2% gain for the Dow Industrials [2]. The company's shares last traded at $84.25, below the median price target of $100, with 27 analyst ratings, including six 'strong buy,' ten 'buy,' and eleven 'hold' ratings [2].
References:
[1] How To Earn $500 A Month From Merck Stock Ahead Of Q2 Earnings. Benzinga. Retrieved from https://www.aol.com/earn-500-month-merck-stock-141223951.html
[2] Merck & Co MRK shares off ~0.6% on Mon ahead of Q2 financial report due before market open on Tues. Reuters. Retrieved from https://www.tradingview.com/news/reuters.com,2025:newsml_L6N3TP0SD:0-preview-merck-seen-reporting-q2-eps-drop-yr-yr-rev-increase/
[3] Merck Q2 Earnings Preview: What to Expect. Seeking Alpha. Retrieved from https://seekingalpha.com/news/4472805-merck-q2-earnings-preview-what-to-expect
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet